Over-expression of glutathione S -transferase in transgenic rice enhances germination and growth at low temperature
These are one of, if not the most rigorously studied class of peptides ever, with many large, placebo-controlled, randomized trials that followed over the past twenty years from the original GLP-1 drugs such as exenatide, approved by the FDA in 2005
Notably, research indicates that individuals most interested in trying GLP-1 medications, and willing to accept common side effects, are those who report greater body shame, body surveillance, weight concerns, anti-fat bias, disordered eating behaviors, and higher BMIs, alongside lower body appreciation and body neutrality (Markey et al., 2025)
PlexusDx extends this precision further by combining compounded GLP-1 optionsoften more affordable and flexiblewith optional Precision Peptide Genetic Testing that may provide context about individual peptide pathway variants